Share
CNBC Pro

Watch CNBC's full interview with Eli Lilly CEO David Ricks following Q3 earnings

Eli Lilly CEO David Ricks joins 'Squawk Box' to react to the company's latest quarterly earnings, which missed Wall Street's estimates. Ricks also provides an update into the company's highly watched Alzheimer's drug donanemab and provides an outlook for Lilly's Covid-19 antibodies.
08:58
Tue, Oct 26 20218:17 AM EDT

watch now
VIDEO08:01
CNBC ProFormer Walmart U.S. CEO on the challenges facing retail
watch now
VIDEO11:56
CNBC ProDr. Scott Gottlieb on what we still need to learn about the new Covid variant
watch now
VIDEO07:21
CNBC ProFundstrat's Tom Lee on market sell-off, Federal Reserve, and more
watch now
VIDEO06:34
CNBC ProSell-off proves 'scars' of Covid are still there, says Bleakley Group CIO
watch now
VIDEO05:36
CNBC ProCashin on new Covid variant and it's impact on markets